Literature DB >> 27421543

Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.

David S Knopman1, Clifford R Jack2, Heather J Wiste2, Stephen D Weigand2, Prashanthi Vemuri2, Val J Lowe2, Kejal Kantarci2, Jeffrey L Gunter2, Matthew L Senjem2, Michelle M Mielke2, Mary M Machulda2, Rosebud O Roberts2, Bradley F Boeve2, David T Jones2, Ronald C Petersen2.   

Abstract

OBJECTIVE: To examine neurodegenerative imaging biomarkers in Alzheimer disease (AD) dementia from middle to old age.
METHODS: Persons with AD dementia and elevated brain β-amyloid with Pittsburgh compound B (PiB)-PET imaging underwent [(18)F]-fluorodeoxyglucose (FDG)-PET and structural MRI. We evaluated 3 AD-related neurodegeneration biomarkers: hippocampal volume adjusted for total intracranial volume (HVa), FDG standardized uptake value ratio (SUVR) in regions of interest linked to AD, and cortical thickness in AD-related regions of interest. We examined associations of each biomarker with age and evaluated age effects on cutpoints defined by the 90th percentile in AD dementia. We assembled an age-, sex-, and intracranial volume-matched group of 194 similarly imaged clinically normal (CN) persons.
RESULTS: The 97 participants with AD dementia (aged 49-93 years) had PiB SUVR ≥1.8. A nonlinear (inverted-U) relationship between FDG SUVR and age was seen in the AD group but an inverse linear relationship with age was seen in the CN group. Cortical thickness had an inverse linear relationship with age in AD but a nonlinear (flat, then inverse linear) relationship in the CN group. HVa showed an inverse linear relationship with age in both AD and CN groups. Age effects on 90th percentile cutpoints were small for FDG SUVR and cortical thickness, but larger for HVa.
CONCLUSIONS: In persons with AD dementia with elevated PiB SUVR, values of each neurodegeneration biomarker were associated with age. Cortical thickness had the smallest differences in 90th percentile cutpoints from middle to old age, and HVa the largest differences.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27421543      PMCID: PMC4999168          DOI: 10.1212/WNL.0000000000002979

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  Longitudinal changes in cortical thickness associated with normal aging.

Authors:  Madhav Thambisetty; Jing Wan; Aaron Carass; Yang An; Jerry L Prince; Susan M Resnick
Journal:  Neuroimage       Date:  2010-05-02       Impact factor: 6.556

2.  Effects of age on the glucose metabolic changes in mild cognitive impairment.

Authors:  Kejal Kantarci; M L Senjem; V J Lowe; H J Wiste; S D Weigand; B J Kemp; A R Frank; M M Shiung; B F Boeve; D S Knopman; R C Petersen; C R Jack
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

3.  Hippocampal atrophy in Alzheimer disease: age matters.

Authors:  L A van de Pol; A Hensel; F Barkhof; H J Gertz; P Scheltens; W M van der Flier
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

4.  Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.

Authors:  I Driscoll; C Davatzikos; Y An; X Wu; D Shen; M Kraut; S M Resnick
Journal:  Neurology       Date:  2009-06-02       Impact factor: 9.910

5.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y C Xu; S C Waring; P C O'Brien; E G Tangalos; G E Smith; R J Ivnik; E Kokmen
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

6.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

7.  Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; David S Knopman; Prashanthi Vemuri; Michelle M Mielke; Val Lowe; Matthew L Senjem; Jeffrey L Gunter; Mary M Machulda; Brian E Gregg; V Shane Pankratz; Walter A Rocca; Ronald C Petersen
Journal:  JAMA Neurol       Date:  2015-05       Impact factor: 18.302

Review 8.  What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.

Authors:  Anders M Fjell; Linda McEvoy; Dominic Holland; Anders M Dale; Kristine B Walhovd
Journal:  Prog Neurobiol       Date:  2014-02-16       Impact factor: 11.685

9.  Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.

Authors:  Manja Lehmann; Pia M Ghosh; Cindee Madison; Anna Karydas; Giovanni Coppola; James P O'Neil; Yadong Huang; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-21       Impact factor: 10.154

10.  Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; Walter A Rocca; David S Knopman; Michelle M Mielke; Val J Lowe; Matthew L Senjem; Jeffrey L Gunter; Gregory M Preboske; Vernon S Pankratz; Prashanthi Vemuri; Ronald C Petersen
Journal:  Lancet Neurol       Date:  2014-09-04       Impact factor: 44.182

View more
  11 in total

Review 1.  Future Directions in Imaging Neurodegeneration.

Authors:  Joseph C Masdeu
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

Review 2.  Alzheimer Disease: Scientific Breakthroughs and Translational Challenges.

Authors:  Richard J Caselli; Thomas G Beach; David S Knopman; Neill R Graff-Radford
Journal:  Mayo Clin Proc       Date:  2017-06       Impact factor: 7.616

3.  Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers.

Authors:  Catherine M Roe; Beau M Ances; Denise Head; Ganesh M Babulal; Sarah H Stout; Elizabeth A Grant; Jason Hassenstab; Chengjie Xiong; David M Holtzman; Tammie L S Benzinger; Suzanne E Schindler; Anne M Fagan; John C Morris
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

4.  Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.

Authors:  Rosebud O Roberts; David S Knopman; Jeremy A Syrjanen; Jeremiah A Aakre; Maria Vassilaki; Walter K Kremers; Michelle M Mielke; Mary M Machulda; Jonathan Graff-Radford; Yonas E Geda; Prashanthi Vemuri; Val Lowe; Clifford R Jack; Ronald C Petersen
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

5.  Joint associations of β-amyloidosis and cortical thickness with cognition.

Authors:  David S Knopman; Emily S Lundt; Terry M Therneau; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Mary M Machulda; Rosebud O Roberts; Bradley F Boeve; David T Jones; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2018-02-02       Impact factor: 4.673

6.  Early-but Not Late-Onset Hypertension Is Related to Midlife Cognitive Function.

Authors:  Karri Suvila; Joao A C Lima; Yuichiro Yano; Zaldy S Tan; Susan Cheng; Teemu J Niiranen
Journal:  Hypertension       Date:  2021-01-19       Impact factor: 9.897

7.  Patterns of progressive atrophy vary with age in Alzheimer's disease patients.

Authors:  Cassidy M Fiford; Gerard R Ridgway; David M Cash; Marc Modat; Jennifer Nicholas; Emily N Manning; Ian B Malone; Geert Jan Biessels; Sebastien Ourselin; Owen T Carmichael; M Jorge Cardoso; Josephine Barnes
Journal:  Neurobiol Aging       Date:  2017-11-14       Impact factor: 4.673

8.  Creating three dimensional models of Alzheimer's disease.

Authors:  Matthew Marks; Amy Alexander; Joseph Matsumoto; Jane Matsumoto; Jonathan Morris; Ronald Petersen; Clifford Jack; Tatsuya Oishi; David Jones
Journal:  3D Print Med       Date:  2017-11-21

9.  An efficient algorithm for estimating brain covariance networks.

Authors:  Marcela I Cespedes; James McGree; Christopher C Drovandi; Kerrie Mengersen; James D Doecke; Jurgen Fripp
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

10.  Norms for Automatic Estimation of Hippocampal Atrophy and a Step Forward for Applicability to the Italian Population.

Authors:  Silvia De Francesco; Samantha Galluzzi; Nicola Vanacore; Cristina Festari; Paolo Maria Rossini; Stefano F Cappa; Giovanni B Frisoni; Alberto Redolfi
Journal:  Front Neurosci       Date:  2021-06-28       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.